Top Markets
#1 ADO Protocol ADO Protocol +328.21%
#2 GoPlus Security GoPlus Security +53.42%
#3 Starpower Starpower +46.46%
#4 Nockchain Nockchain +36.58%
#5 Tutorial Tutorial +34.27%
#6 Verus Coin Verus Coin +33.47%
#7 The Black Bull The Black Bull +24.82%
#8 GAIB AID GAIB AID +24.67%
#9 Chainflip Chainflip +23.90%
#10 peaq peaq +19.76%
Coin of the day
ADO Protocol ADO Protocol
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Classificação em ações #32479
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Preço da ação
$0.69957862
Valor de mercado
$9.99M
Variação (1 dia)
-0.90%
Variação (1 ano)
18.70%
País
TW
Negociar RBC Bioscience Corporation (6848)

Categoria

Healthcare
Lucros da RBC Bioscience Corporation (6848)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da RBC Bioscience Corporation, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da RBC Bioscience Corporation de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE